Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
29.37
-0.87 (-2.88%)
Jan 30, 2026, 12:11 PM EST - Market open
Viking Therapeutics Employees
As of September 30, 2025, Viking Therapeutics had 51 total employees, including 50 full-time and 1 part-time employees. The number of employees increased by 20 or 64.52% compared to the same quarter last year.
Employees
51
Change
20
Growth
64.52%
Revenue / Employee
n/a
Profits / Employee
-$4,654,784
Market Cap
3.32B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| Denali Therapeutics | 517 |
| Xenon Pharmaceuticals | 327 |
| Alumis | 223 |
| Liquidia | 170 |
| Vera Therapeutics | 112 |
| Erasca | 103 |
| NewAmsterdam Pharma Company | 77 |
VKTX News
- 17 days ago - Viking Therapeutics, Inc. (VKTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Appetite for weight-loss deals broader than visible, Viking CEO says - Reuters
- 18 days ago - Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity - PRNewsWire
- 22 days ago - Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity - PRNewsWire
- 23 days ago - Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer - PRNewsWire
- 24 days ago - Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 25 days ago - Novo Nordisk's weight-loss pill is available. Here's why Lilly's and Viking's stocks are down. - Market Watch
- 27 days ago - Viking Therapeutics: The Obesity Drugs Gold Rush Is Far From Over - Seeking Alpha